Bangladesh to host ESMO Examination 2025
In a proud moment for the nation, Bangladesh has been selected to host a local session of the ESMO Examination 2025, a globally recognised assessment conducted by the European Society for Medical Oncology (ESMO).
This marks the first time that the exam, widely regarded as the international benchmark for professional excellence in oncology, will be held in the country.
The ESMO Examination is taken by medical oncologists worldwide and serves as a standard for clinical knowledge and global best practices in cancer care. Having Bangladesh included in the list of parallel host countries is a significant step forward for the country's medical education and healthcare community.
Keep updated, follow The Business Standard's Google news channel
The exam will be held at a recognised academic institution in Dhaka under ESMO's official guidelines and supervision. This inclusion reflects years of progress in the country's oncology infrastructure, medical training, and growing alignment with international standards.
With the available opportunity at home, local oncologists will no longer need to travel abroad to sit for this critical exam. This development is expected to boost participation, reduce barriers to global certification, and further strengthen cancer care standards in Bangladesh.
Health experts view this milestone as a sign of Bangladesh's increasing role in the global healthcare landscape, especially in oncology, where the demand for skilled, globally certified professionals is rapidly growing.
The ESMO Examination's arrival in Dhaka is not just a logistical update—it reflects the country's rising capabilities in advanced healthcare, academic leadership, and international collaboration.
